Mickaël Ohanna

2.8k total citations
27 papers, 2.1k citations indexed

About

Mickaël Ohanna is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Mickaël Ohanna has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Mickaël Ohanna's work include Melanoma and MAPK Pathways (4 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). Mickaël Ohanna is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). Mickaël Ohanna collaborates with scholars based in France, United States and Switzerland. Mickaël Ohanna's co-authors include Robert Ballotti, Corine Bertolotto, Yann Chéli, Mario Pende, Athanassia Sotiropoulos, Paul A. Kelly, Stéphane Rocchi, J.‐P. Lacour, Karine Bille and Sandy Giuliano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Mickaël Ohanna

27 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mickaël Ohanna France	21	1.4k	518	503	363	282	27	2.1k
Enzo Calautti United States	23	1.5k 1.1×	684 1.3×	615 1.2×	310 0.9×	231 0.8×	38	2.3k
Virginie Mieulet France	15	1.9k 1.4×	326 0.6×	423 0.8×	319 0.9×	507 1.8×	17	2.6k
Steven Swendeman United States	27	1.7k 1.2×	283 0.5×	599 1.2×	508 1.4×	267 0.9×	35	2.6k
Günter Daum United States	27	1.7k 1.2×	341 0.7×	321 0.6×	357 1.0×	250 0.9×	55	2.5k
David Shahbazian United States	15	2.1k 1.5×	356 0.7×	560 1.1×	421 1.2×	292 1.0×	17	2.8k
Jean‐Marc Brondello France	21	2.0k 1.4×	277 0.5×	413 0.8×	362 1.0×	548 1.9×	43	2.9k
Tianquan Zhu China	6	2.1k 1.6×	372 0.7×	312 0.6×	287 0.8×	228 0.8×	7	2.8k
Maria De La Luz Sierra United States	21	1.0k 0.8×	421 0.8×	386 0.8×	353 1.0×	180 0.6×	33	2.0k
Fred E. Indig United States	31	2.5k 1.8×	550 1.1×	535 1.1×	379 1.0×	542 1.9×	55	3.5k

Countries citing papers authored by Mickaël Ohanna

Since Specialization

Citations

This map shows the geographic impact of Mickaël Ohanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mickaël Ohanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mickaël Ohanna more than expected).

Fields of papers citing papers by Mickaël Ohanna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mickaël Ohanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mickaël Ohanna. The network helps show where Mickaël Ohanna may publish in the future.

Co-authorship network of co-authors of Mickaël Ohanna

This figure shows the co-authorship network connecting the top 25 collaborators of Mickaël Ohanna. A scholar is included among the top collaborators of Mickaël Ohanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mickaël Ohanna. Mickaël Ohanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ohanna, Mickaël, Marie Irondelle, Stéphane Audebert, et al.. (2025). USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization. Cell Reports. 44(10). 116372–116372. 1 indexed citations

Brest, Patrick, Marcel Deckert, Mickaël Ohanna, et al.. (2024). Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation. Journal of Experimental & Clinical Cancer Research. 43(1). 335–335. 1 indexed citations

Ohanna, Mickaël, et al.. (2022). Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma Pathogenesis. Cancers. 14(14). 3371–3371. 6 indexed citations

Ohanna, Mickaël, et al.. (2022). The Stress-Responsive microRNA-34a Alters Insulin Signaling and Actions in Adipocytes through Induction of the Tyrosine Phosphatase PTP1B. Cells. 11(16). 2581–2581. 9 indexed citations

Berestjuk, Ilona, Virginie Prod’homme, Mickaël Ohanna, et al.. (2021). Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma. EMBO Molecular Medicine. 14(2). e11814–e11814. 49 indexed citations

Rathore, Moeez, Christophe A. Girard, Mickaël Ohanna, et al.. (2019). Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway. Oncogene. 38(30). 5873–5889. 64 indexed citations

Giuliano, Sandy, Maeva Dufies, Papa Diogop Ndiaye, et al.. (2019). Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5. Theranostics. 9(4). 1181–1199. 24 indexed citations

Mallavialle, Aude, Mélanie Tichet, Patrick Auberger, et al.. (2018). Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies. Molecular Cancer Therapeutics. 17(7). 1416–1429. 44 indexed citations

Bertolotto, Corine, Mickaël Ohanna, & Robert Ballotti. (2018). Transition des cellules de mélanome vers un phénotype invasif et pharmacorésistant. médecine/sciences. 34(12). 1025–1028. 1 indexed citations

10.

Ohanna, Mickaël, Michaël Cerezo, Nicolas Nottet, et al.. (2018). Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype. Genes & Development. 32(5-6). 448–461. 59 indexed citations

11.

Rouaud, Florian, Michaël Cerezo, Patricia Abbe, et al.. (2018). E2F1 inhibition mediates cell death of metastatic melanoma. Cell Death and Disease. 9(5). 527–527. 31 indexed citations

12.

Zangari, Joséphine, Marius Ilié, Florian Rouaud, et al.. (2016). Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition. Nucleic Acids Research. 45(7). gkw1284–gkw1284. 32 indexed citations

13.

Tichet, Mélanie, Virginie Prod’homme, Nina Fenouille, et al.. (2015). Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis. Nature Communications. 6(1). 6993–6993. 157 indexed citations

14.

Cerezo, Michaël, Mélanie Tichet, Patricia Abbe, et al.. (2013). Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner. Molecular Cancer Therapeutics. 12(8). 1605–1615. 174 indexed citations

15.

Ohanna, Mickaël, Sandy Giuliano, Caroline Bonet, et al.. (2011). Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS). Genes & Development. 25(12). 1245–1261. 209 indexed citations

16.

Fenouille, Nina, Alexandre Puissant, Maeva Dufies, et al.. (2010). Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC. Cancer Research. 70(23). 9659–9670. 52 indexed citations

17.

Giuliano, Sandy, Yann Chéli, Mickaël Ohanna, et al.. (2010). Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas. Cancer Research. 70(9). 3813–3822. 98 indexed citations

18.

Chéli, Yann, Mickaël Ohanna, Robert Ballotti, & Corine Bertolotto. (2009). Fifteen-year quest for microphthalmia-associated transcription factor target genes. Pigment Cell & Melanoma Research. 23(1). 27–40. 275 indexed citations

19.

Mieulet, Virginie, Mila Roceri, Athanassia Sotiropoulos, et al.. (2007). S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover. American Journal of Physiology-Cell Physiology. 293(2). C712–C722. 78 indexed citations

20.

Ohanna, Mickaël, Andrew K. Sobering, Thomas Lapointe, et al.. (2005). Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nature Cell Biology. 7(3). 286–294. 317 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact